ENTITY
Hanyu Pharmaceutical
Hanyu Pharmaceutical
PulseAugur coverage of Hanyu Pharmaceutical — every cluster mentioning Hanyu Pharmaceutical across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-05-19 funding Hanyu Pharmaceutical signed a framework agreement for peptide API sales with a minimum value of 327 million yuan. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
KaiDi Co. clarifies robot products in development, not generating revenue
KaiDi Co. announced that its robot-related products are still in the development phase and will not generate revenue in the short term. The company's stock experienced significant price fluctuations, prompting this clar…
-
Hanyu Pharmaceutical secures 327M yuan peptide API sales deal
Hanyu Pharmaceutical has entered into a framework agreement for the sale of peptide APIs with a partner, aiming for a minimum sales value of 327 million yuan. This agreement, signed on May 18th, is intended to expand th…